Researchers successfully developed a machine learning-based method for predicting symptom deterioration in patients with cancer.

Monoclonal antibody (mAb) manufacturing must continually improve to keep up with increasing demands. To do this, biomanufacturers can deploy machine learning tools to augment traditional process ...

IOP Publishing’s Machine Learning series is the world’s first open-access journal series dedicated to the application and ...